ABI-007 (nab-paclitaxel)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABI-007 (nab-paclitaxel), covering 2014-09-19 to 2017-01-31. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy of ABI-007 Plus Gemcitabine or sLV5FU2 as First-line Therapy in Patients With Metastatic Pancreatic Cancer [Phase 2]